Antifungal Drugs Flashcards
Polyene antibiotics
Amphotericin B
Natamycin
Nystatin
Polyene antibiotics - MoA
Binds to ergosterol in cell membrane, increasing membrane permeability and leakage of cell contents
Amphotericin B - Clinical use
Systemic and subcutaneous mycoses
Superficial infections
Cryptococcal meningitis Candidiasis Coccidioidomycosis Aspergillosis Blastomycosis Histoplasmosis Mucormycosis Protozoa: leishmaniasis and amebic encephalitis
Amphotericin B - Adverse effects
Most toxic antibiotic today
Renal toxicity in 80%, it reduces the GFR and contributes to development of hypokalemia and hypomagnesemia
Azotemia (Accumulation of creatinine and urea in blood)
Acute liver failure Cardiac arrhythmias (Ventricular fibrillation)
Hematopoietic disorders (anemia, leukopenia, thrombocytopenia)
Amphotericin B - Contraindications
Contraindicated for patients with renal impairment (should use lipid formulations for these patients)
Amphotericin B - Special considerations
Electrolytes should be monitored weekly during treatment
Amphotericin B - Interactions
Cyclosporine, antineoplasics, thiazides, corticosteroids: increased hypokalemia
Natamycin - Clinical use
Superficial mycoses of skin and mucous membranes
Aspergillus
Candida
Fusarium
Penicillum
Opthalmic suspension for the treatment of fungal blepharitis, conjunctivitis, or keratitis
Nystatin - Clinical use
Superficial mycoses of skin and mucous membranes
Candida (mucocutaneous, intestinal, vaginal)
Diazole derivatives
Clotrimazole
Econazole
Ketoconazole
Diazole derivatives - MoA
Inhibits ergosterol synthesis
Clotrimazole - Clinical use
Candidia infection in mouth, throat, vagina, vulva
M. furfur infection in skin (tinea versicolor)
Dermatophyte infections (tinea pedis and tinea cruris) due to epidermophyton, microsporum, trichophyton sp.
Econazole - Clinical use
Candidia and dermatophyte infections of skin
Ketoconazole - Clinical use
Seborrheic dermatitis
Inoperable cushing syndrome
Once-daily dose for chronic mucocutanous candidiasis
Diazole and Triazole derivatives - Adverse effects
Systemic administration can cause: Skin rash Elevated liver enzyme levels Hepatic injury Hematopoietic toxicity GI distress
Azole derivatives - Interactions
Inhibits CYP3A4: inhibited metabolism of HMG-CoA reductase inhibitors, benzodiazepines, quinidine, warfarin
Triazole derivatives
Fluconazole Itraconazole Posaconazole Voriconazole Isavuconazonium Efinaconazole
Triazole derivative - MoA
Inhibition of ergosterol synthesis
Fluconazole - Clinical use
Prevention of cryptococcal meninitis in patients with AIDS, and a follow-up therapy in patients successfully treated with amphotericin B to prevent relapse
Coccidioidal meningitis
Mucocutaneous (oropharyngeal and esophageal) and disseminated candidiasis such as endocardial candidiasis
UTIs by Candida
Vaginal candidiasis (single dose) Inoperable cushing syndrome
Fluconazole - Contraindications
Contraindicated during first trimester of pregnancy because of increased risk of birth defects